<VariationArchive VariationID="662854" VariationName="NC_000007.14:g.(?_124823952)_(124897183_?)del" VariationType="Deletion" Accession="VCV000662854" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="651638" VariationID="662854">
      <GeneList>
        <Gene Symbol="POT1" FullName="protection of telomeres 1" GeneID="25913" HGNC_ID="HGNC:17284" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="124822386" stop="124929825" display_start="124822386" display_stop="124929825" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="124462439" stop="124570036" display_start="124462439" display_stop="124570036" Strand="-" />
          </Location>
          <OMIM>606478</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.14:g.(?_124823952)_(124897183_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" innerStart="124823952" innerStop="124897183" display_start="124823952" display_stop="124897183" variantLength="73232" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="124464006" innerStop="124537237" display_start="124464006" display_stop="124537237" variantLength="73232" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.(?_124823952)_(124897183_?)del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.(?_124823952)_(124897183_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_124464006)_(124537237_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_124464006)_(124537237_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.14:g.(?_124823952)_(124897183_?)del AND Tumor predisposition syndrome 3" Accession="RCV000820595" Version="4">
        <ClassifiedConditionList TraitSetID="16369">
          <ClassifiedCondition DB="MedGen" ID="C4014476">Tumor predisposition syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32155570</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="16369" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21232" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melanoma, cutaneous malignant, susceptibility to, 10</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumor predisposition syndrome 3</ElementValue>
                <XRef ID="MONDO:0014368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LONG TELOMERE SYNDROME, POT1-RELATED</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glioma susceptibility 9</ElementValue>
                <XRef ID="MONDO:0014695" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS3</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMM10</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLM9</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18582" />
                <XRef ID="18582" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">POT1 tumor predisposition (POT1-TPD) is characterized by an increased lifetime risk for multiple cutaneous melanomas, chronic lymphocytic leukemia (CLL), angiosarcoma (particularly cardiac angiosarcomas), and gliomas. Additional cancers (e.g., colorectal cancer, thyroid cancer, breast angiosarcomas) have been reported in individuals with POT1-TPD but with very limited evidence. The age of onset for first primary cutaneous melanoma ranges from 15 to 80 years. The majority of POT1 associated cancers are diagnosed in adulthood.</Attribute>
                <XRef ID="NBK563529" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33119245</ID>
                <ID Source="BookShelf">NBK563529</ID>
              </Citation>
              <XRef ID="618" DB="Orphanet" />
              <XRef ID="C4014476" DB="MedGen" />
              <XRef ID="MONDO:0014368" DB="MONDO" />
              <XRef Type="MIM" ID="615848" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1855634" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_015450.2_7_Deletion (entire coding sequence)_124464005_124537237|MedGen:C4014476" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000961312" DateUpdated="2022-05-16" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32155570</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the POT1 gene has been identified. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with POT1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_124464006)_(124537237_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014476" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1855634" TraitType="Disease" MappingType="XRef" MappingValue="C4014476" MappingRef="MedGen">
        <MedGen CUI="C4014476" Name="Tumor predisposition syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

